Research Catalog
Pathway to protection : expanding availability of COVID-19 vaccines : virtual hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventeenth Congress, first session, February 23, 2021.
- Title
- Pathway to protection : expanding availability of COVID-19 vaccines : virtual hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventeenth Congress, first session, February 23, 2021.
- Author
- United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations, author.
- Publication
- Washington : U.S. Government Publishing Office, 2022.
Available Online
Details
- Description
- 1 online resource (v, 133 pages) : color illustrations
- Alternative Title
- Expanding availability of COVID-19 vaccines
- Subject
- Genre/Form
- Legislative hearings.
- Note
- Access ID (govinfo): CHRG-117hhrg45576.
- "Serial no. 117-7."
- Bibliography (note)
- Includes bibliographical references.
- Event (note)
- Date of hearing: 2021-02-23.
- Source of Description (note)
- Description based on online resource; title from PDF title page (GovInfo, viewed Oct. 29, 2022).
- Call Number
- GPO Internet Y 4.C 73/8:117-7
- LCCN
- 45-576
- OCLC
- marcive1349358374
- Author
- United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations, author.
- Title
- Pathway to protection : expanding availability of COVID-19 vaccines : virtual hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventeenth Congress, first session, February 23, 2021.
- Publisher
- Washington : U.S. Government Publishing Office, 2022.
- Type of Content
- text
- Type of Medium
- computer
- Type of Carrier
- online resource
- Bibliography
- Includes bibliographical references.
- Performer
- Hearing witnesses: John Young, Chief Business Officer, Pfizer; Stephen Hoge, M.D., President, Moderna, Inc; Richard Nettles, M.D., Vice President of U.S. Medical Affairs, Janssen Infectious Diseases and Vaccines, Johnson & Johnson; Ruud Dobber, Ph.D., Executive Vice President, BioPharmaceuticals Business Unit, and President, North America, AstraZeneca; John Trizzino, Executive Vice President, Chief Commercial Officer, and Chief Business Officer, Novavax.
- Event
- Date of hearing: 2021-02-23.
- Connect to:
- Other Form:
- Print version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. Pathway to protection (OCoLC)1349358310
- Other Standard Identifier
- 45-576 (GPO jacket number)
- Gpo Item No.
- 1019-C-01 (online)
- Sudoc No.
- Y 4.C 73/8:117-7